888022-42-2

Basic information

• Product Name: (5-METHYLOXAZOL-2-YL)METHANOL
• Synonyms: (5-METHYLOXAZOL-2-YL)METHANOL;(5-methyl-1,3-oxazol-2-yl)methanol
• CAS NO: 888022-42-2
• Molecular Formula: C5H7NO2
• Molecular Weight: 113.11
• Mol File: 888022-42-2.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (5-METHYLOXAZOL-2-YL)METHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: (5-METHYLOXAZOL-2-YL)METHANOL(888022-42-2)
• EPA Substance Registry System: (5-METHYLOXAZOL-2-YL)METHANOL(888022-42-2)

Safety Data

• Hazardous Substances Data: 888022-42-2(Hazardous Substances Data)

Usage

General Description

(5-METHYLOXAZOL-2-YL)METHANOL is a chemical compound with the molecular formula C4H7NO2. It is an oxazole derivative with a methyl group attached to the oxazole ring. (5-METHYLOXAZOL-2-YL)METHANOL has potential applications in the pharmaceutical and chemical industries due to its structural properties and potential reactivity. It may be used in organic synthesis, as a building block for the production of other compounds, or in medicinal chemistry for the development of new drugs. The presence of the oxazole ring and the methyl group makes this compound an interesting candidate for further investigation and potential use in various chemical and biological processes.

Upstream product

• 33123-68-1 ethyl 5-methyloxazole-2-carboxylate 
• 33115-97-8 ethyl 2-oxo-2-((2-oxopropyl)amino)acetate 
• 754202-89-6 ethyl 2-((2-hydroxypropyl)amino)-2-oxoacetate 
• 888022-41-1 5-methyloxazol-2-ylmethyl acetate 

Relevant articles and documents

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound useful in the treatment of a neurodegenerative disorder and their combined use as a medicament, in particular for the treatment of neurodegenerative and/or cognitive disorders.

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound which compound is useful in the treatment of a psychiatric disorder and their combined use as a medicament, in particular for the treatment of psychiatric and/or cognitive disorders.

1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.